The mono-amine oxidase inhibitors; their usefulness and their safety.
D000293:Adolescent; D000328:Adult; D002746:Chlorpromazine / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010293:Pargyline / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy*; D014191:Tranylcypromine / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D014191:Tranylcypromine; D010293:Pargyline; D002746:Chlorpromazine